30/JUL/12

Neuron BioPharma attends the Alzheimer’s Association International Conference AAIC 2012

Neuron BioPharma attended the Alzheimer’s Association International Conference AAIC 2012 held in Vancouver (Canada) from 14 to 19 July. During the conference the company’s representatives kept their contacts up to date with the latest advances concerning compound NST0037, a potential treatment for Alzheimer’s disease.

The conference, organised by the Alzheimer’s Association (Alz.org), was a meeting point for the International scientific community, where new developments in the study of the Alzheimer’s disease could be looked at and discussed.

More than 4,000 international experts attended the event, at which some 2,500 talks were given.